Bayer AG
XETRA:BAYN
Bayer AG
Note Receivable
Bayer AG
Note Receivable Peer Comparison
Competitive Note Receivable Analysis
Latest Figures & CAGR of Competitors
Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Note Receivable
€1.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Note Receivable
$11.3m
|
CAGR 3-Years
78%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Note Receivable
€37m
|
CAGR 3-Years
14%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
MPH Health Care AG
XETRA:93M1
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Note Receivable?
Note Receivable
1.1B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Note Receivable amounts to 1.1B EUR.
What is Bayer AG's Note Receivable growth rate?
Note Receivable CAGR 10Y
9%
Over the last year, the Note Receivable growth was 6%.